Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease
The intracellular sensing protein termed NLRP3 (for NACHT, LRR, and PYD domains-
containing protein 3) forms a macromolecular structure called the NLRP3 inflammasome …
containing protein 3) forms a macromolecular structure called the NLRP3 inflammasome …
Inflammation in Heart Failure: JACC State-of-the-Art Review
It has long been observed that heart failure (HF) is associated with measures of systemic
inflammation. In recent years, there have been significant advancements in our …
inflammation. In recent years, there have been significant advancements in our …
The NLRP3 inflammasome in acute myocardial infarction
The heart is extremely sensitive to ischaemic injury. During an acute myocardial infarction
(AMI) event, the injury is initially caused by reduced blood supply to the tissues, which is …
(AMI) event, the injury is initially caused by reduced blood supply to the tissues, which is …
The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
An intense, stereotyped inflammatory response occurs in response to ischaemic and non-
ischaemic injury to the myocardium. The NACHT, LRR and PYD domains-containing protein …
ischaemic injury to the myocardium. The NACHT, LRR and PYD domains-containing protein …
Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury
Myocardial ischemia-reperfusion injury induces a sterile inflammatory response, leading to
further injury that contributes to the final infarct size. Locally released danger-associated …
further injury that contributes to the final infarct size. Locally released danger-associated …
Management of myocarditis-related cardiomyopathy in adults
Myocarditis is generally a mild and self-limited consequence of systemic infection of
cardiotropic viruses. However, patients can develop a temporary or permanent impairment …
cardiotropic viruses. However, patients can develop a temporary or permanent impairment …
Inflammation in human heart failure: major mediators and therapeutic targets
M Reina-Couto, P Pereira-Terra… - Frontiers in …, 2021 - frontiersin.org
Inflammation has been recognized as a major pathophysiological contributor to the entire
spectrum of human heart failure (HF), including HF with reduced ejection fraction, HF with …
spectrum of human heart failure (HF), including HF with reduced ejection fraction, HF with …
Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction
Background ST‐segment–elevation myocardial infarction is associated with an intense
acute inflammatory response and risk of heart failure. We tested whether interleukin‐1 …
acute inflammatory response and risk of heart failure. We tested whether interleukin‐1 …
Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies
A Aimo, V Castiglione, C Borrelli… - European journal of …, 2020 - journals.sagepub.com
Both oxidative stress and inflammation are enhanced in chronic heart failure. Dysfunction of
cardiac mitochondria is a hallmark of heart failure and a leading cause of oxidative stress …
cardiac mitochondria is a hallmark of heart failure and a leading cause of oxidative stress …
Anakinra therapy for non-cancer inflammatory diseases
G Cavalli, CA Dinarello - Frontiers in pharmacology, 2018 - frontiersin.org
Interleukin-1 (IL-1) is the prototypical inflammatory cytokine: two distinct ligands (IL-1α and IL-
1β) bind the IL-1 type 1 receptor (IL-1R1) and induce a myriad of secondary inflammatory …
1β) bind the IL-1 type 1 receptor (IL-1R1) and induce a myriad of secondary inflammatory …